Quick Takeaways
- Edward J. Benz Jr. has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Edward J. Benz Jr.
- Location
- Waltham, MA
- Signature
- /s/ Charles Schoch, as Attorney-In-Fact for Edward J. Benz Jr.
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Edward J. Benz Jr. and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Deciphera Pharmaceuticals, Inc. ($0).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Edward J. Benz Jr.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| Deciphera Pharmaceuticals, Inc. | Director | $0 | 11 Jun 2024 | |||
| CADL | Candel Therapeutics, Inc. | Director | 17 Jun 2025 | |||
| RCOR | Renovacor, Inc. | Director | 01 Dec 2022 |
Insider Transactions Reported by Edward J. Benz Jr.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.